PLURISTEM THERAPEUTICSCS INC
PLURISTEM THERAPEUTICSCS INC
Action · US72940R3003 · PSTI · A2PPB4 (XNMS)
Aperçu Indicateurs financiers
Pas de cours
n/a

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
- - - - 0,00 % 0,00 % -87,05 %

Profil de l'entreprise pour PLURISTEM THERAPEUTICSCS INC Action

Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18, which has completed Phase I clinical trial incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as conducts various animal studies for the evaluation of PLX-R18 for the treatment of acute radiation syndrome. The company has a license agreement for conducting clinical trials of PLX-PAD product in South Korea. It also has a collaborative project nTRACK, that examines gold nano particles labeling of stem cells; and has collaboration agreement with the NASA's Ames Research Center to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel.

Données de l'entreprise

Nom PLURISTEM THERAPEUTICSCS INC
Société Pluristem Therapeutics Inc.
Symbole PSTI
Site web https://www.pluristem.com
Marché d'origine XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A2PPB4
ISIN US72940R3003
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Yaky Yanay
Capitalisation boursière 41 Mio
Pays Israël
Devise USD
Employés 0,2 T
Adresse Matam Advanced Technology Park, Building No. 5, 3508409 Haifa
Date d'introduction en bourse 2007-12-10

Fractionnements d'actions

Date Fractionnement
25.07.2019 1:10
26.11.2007 1:200

Changements d'identifiant

Date De À
28.12.2007 PLRS PSTI

Symboles boursiers

Nom Symbole
NASDAQ PSTI

Autres actions

Les investisseurs qui détiennent PLURISTEM THERAPEUTICSCS INC ont également les actions suivantes dans leur portefeuille :
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Action
AMGEN INC
AMGEN INC Action
AUTODESK INC
AUTODESK INC Action
CINTAS CORP
CINTAS CORP Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
D/B/A CENTERSPACE
D/B/A CENTERSPACE Action
DZ BANK IS.C213 20/35
DZ BANK IS.C213 20/35 Obligation
FRANKFURTER-SPARINRENT
FRANKFURTER-SPARINRENT Fonds
INTEL CORP
INTEL CORP Action
MICROSOFT CORP
MICROSOFT CORP Action
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Action
US TREASURY 2039
US TREASURY 2039 Obligation
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025